Gaudium IVF Lists at 5% Premium, Beats Grey Market Estimates

[{ "selector": ".fkonu-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - 291px)) scale(0.15)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".soxdn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }]

Positive Debut

Gaudium IVF shares opened at ₹83 on BSE and NSE, 5% premium over ₹79 issue price. Investors gained ₹756 per lot (189 shares).

[{ "selector": ".eigzz-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".sauct-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Beat Expectations:

Listing surprised markets as grey market showed zero premium ahead of debut. Stock later surged 10.31% to ₹87.15 intraday high.

[{ "selector": ".cilft-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".lwtlz-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Strong Subscription:

IPO oversubscribed 7.27 times. Raised ₹165 crore through ₹90 crore fresh issue and ₹75 crore OFS at ₹75-79 band.

[{ "selector": ".cftxu-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".kjwlf-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Anchor Support:

MobiliSed ₹49.5 crore from anchor investors pre-IPO. Allotment finalized Feb 25. Market cap now stands at ₹585.93 crore post-listing.

[{ "selector": ".jjroi-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".awnce-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

India's First Listed IVF Player:

Operates 30+ locations via hub-spoke model across 7 states. FY25 revenue ₹70.96 crore, profit ₹19.13 crore. Brokerage recommends long-term subscription.

[{ "selector": ".nqfex-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".zuwbd-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

With Our Subscription Plans

[{ "selector": ".qeeag-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".ktmwg-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".qdinx-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-299px)", "opacity": "1", "visibility" :"visible" }, {"offset": 1, "transform": "translateX(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".buwze-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-33px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Open Demat A/C

Gaudium IVF Lists at 5% Premium, Beats Grey Market Estimates

Positive DebutGaudium IVF shares opened at ₹83 on BSE and NSE, 5% premium over ₹79 issue price. Investors gained ₹756 per lot (189 shares).

Beat Expectations: Listing surprised markets as grey market showed zero premium ahead of debut. Stock later surged 10.31% to ₹87.15 intraday high.

Strong Subscription: IPO oversubscribed 7.27 times. Raised ₹165 crore through ₹90 crore fresh issue and ₹75 crore OFS at ₹75-79 band.

Anchor Support: MobiliSed ₹49.5 crore from anchor investors pre-IPO. Allotment finalized Feb 25. Market cap now stands at ₹585.93 crore post-listing.

India's First Listed IVF Player: Operates 30+ locations via hub-spoke model across 7 states. FY25 revenue ₹70.96 crore, profit ₹19.13 crore. Brokerage recommends long-term subscription.